Women's health company redefining prenatal care delivery to improve the health of women and babies.
Bloomlife is an award winning women’s health company solving the most significant yet underserved global challenges today in maternal health. We are redefining the way prenatal care is delivered by combining connected devices with cloud based data analytics to improve access to care, empower women, and provide clinicians with information to more effectively screen and manage pregnancy complications. Our goal is to become the leading provider of remote care for expectant women globally. Bloomlife’s approach to managing high risk pregnancies allows obstetricians to more easily screen maternal and fetal risk, educate the patient, and quickly access high risk specialists regardless of a patient’s geography. Our solution represents a marked shift from the way high risk pregnancies have been historically assessed using frequent in person appointments, paper logs, and long referral times.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 30, 2019 | Grant | $224.89K | 1 | National Science Foundation | — | Detail |
Nov 7, 2017 | Grant | $2.30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
The Institute for the Promotion of Innovation by Science and Technology in Flanders | — | Grant |